TTANGO, the first randomised trial of a molecular chlamydia and gonorrhoea point-of-care assay

L Natoli; R Guy; B Hengel; L Causer; S Badman; A Tangey; S N Tabrizi; David Whiley; B Donovan; C Fairley; Mark Shephard; D Anderson; H Wand; D Wilson; D Regan; J Ward; J M Kaldor

TTANGO, the first randomised trial of a molecular chlamydia and gonorrhoea point-of-care assay

L Natoli, R Guy, B Hengel, L Causer, S Badman, A Tangey, S N Tabrizi, David Whiley, B Donovan, C Fairley, Mark Shephard, D Anderson, H Wand, D Wilson, D Regan, J Ward, J M Kaldor

Research output: Contribution to conference › Poster

Abstract

Background: Point-of-care (POC) tests for sexually transmitted infections may increase timely diagnosis, treatment and partner notification, and thereby reduce community infection rates. With new, portable and highly accurate molecular diagnostic technology available through the GeneXpert®, we designed TTANGO (Test, Treat ANd GO), to measure the effectiveness, cost-effectiveness, cultural and operational acceptability of POC testing for chlamydia (CT) and gonorrhoea (NG) in remote Australian Aboriginal communities, where these infections occur at high levels. The trial employs a crossover, randomised controlled design at 12 health services in remote Australia. We describe the preparatory phase of the trial.

Original language	English
Pages	251
Number of pages	1
Publication status	Published - 23 Oct 2013
Event	Australasian Sexual Health Conference - Darwin, Australia Duration: 21 Oct 2013 → 25 Oct 2013

Conference

Conference	Australasian Sexual Health Conference
Country/Territory	Australia
City	Darwin
Period	21/10/13 → 25/10/13

Keywords

Chlamydia
Gonorrhoea
Point-of-Care

Access to Document

https://ashm.blob.core.windows.net/ashmpublic/CA13-CA13S%202013_JOINT__ABSTRACTS_V2.pdfLicence: In Copyright

Cite this

Natoli, L., Guy, R., Hengel, B., Causer, L., Badman, S., Tangey, A., Tabrizi, S. N., Whiley, D., Donovan, B., Fairley, C., Shephard, M., Anderson, D., Wand, H., Wilson, D., Regan, D., Ward, J., & Kaldor, J. M. (2013). TTANGO, the first randomised trial of a molecular chlamydia and gonorrhoea point-of-care assay. 251. Poster session presented at Australasian Sexual Health Conference, Darwin, Northern Territory, Australia. https://ashm.blob.core.windows.net/ashmpublic/CA13-CA13S%202013_JOINT__ABSTRACTS_V2.pdf

Natoli, L ; Guy, R ; Hengel, B ; Causer, L ; Badman, S ; Tangey, A ; Tabrizi, S N ; Whiley, David ; Donovan, B ; Fairley, C ; Shephard, Mark ; Anderson, D ; Wand, H ; Wilson, D ; Regan, D ; Ward, J ; Kaldor, J M. / TTANGO, the first randomised trial of a molecular chlamydia and gonorrhoea point-of-care assay. Poster session presented at Australasian Sexual Health Conference, Darwin, Northern Territory, Australia.1 p.

@conference{7aa82996c5ed41e5a759facf6f294df3,

title = "TTANGO, the first randomised trial of a molecular chlamydia and gonorrhoea point-of-care assay",

abstract = "Background: Point-of-care (POC) tests for sexually transmitted infections may increase timely diagnosis, treatment and partner notification, and thereby reduce community infection rates. With new, portable and highly accurate molecular diagnostic technology available through the GeneXpert{\textregistered}, we designed TTANGO (Test, Treat ANd GO), to measure the effectiveness, cost-effectiveness, cultural and operational acceptability of POC testing for chlamydia (CT) and gonorrhoea (NG) in remote Australian Aboriginal communities, where these infections occur at high levels. The trial employs a crossover, randomised controlled design at 12 health services in remote Australia. We describe the preparatory phase of the trial.",

keywords = "Chlamydia, Gonorrhoea, Point-of-Care",

author = "L Natoli and R Guy and B Hengel and L Causer and S Badman and A Tangey and Tabrizi, {S N} and David Whiley and B Donovan and C Fairley and Mark Shephard and D Anderson and H Wand and D Wilson and D Regan and J Ward and Kaldor, {J M}",

year = "2013",

month = oct,

day = "23",

language = "English",

pages = "251",

note = "Australasian Sexual Health Conference ; Conference date: 21-10-2013 Through 25-10-2013",

}

Natoli, L, Guy, R, Hengel, B, Causer, L, Badman, S, Tangey, A, Tabrizi, SN, Whiley, D, Donovan, B, Fairley, C, Shephard, M, Anderson, D, Wand, H, Wilson, D, Regan, D, Ward, J & Kaldor, JM 2013, 'TTANGO, the first randomised trial of a molecular chlamydia and gonorrhoea point-of-care assay', Australasian Sexual Health Conference, Darwin, Australia, 21/10/13 - 25/10/13 pp. 251. <https://ashm.blob.core.windows.net/ashmpublic/CA13-CA13S%202013_JOINT__ABSTRACTS_V2.pdf>

TTANGO, the first randomised trial of a molecular chlamydia and gonorrhoea point-of-care assay. / Natoli, L; Guy, R; Hengel, B; Causer, L; Badman, S; Tangey, A; Tabrizi, S N; Whiley, David; Donovan, B; Fairley, C; Shephard, Mark; Anderson, D; Wand, H; Wilson, D; Regan, D; Ward, J; Kaldor, J M.

2013. 251 Poster session presented at Australasian Sexual Health Conference, Darwin, Northern Territory, Australia.

Research output: Contribution to conference › Poster

TY - CONF

T1 - TTANGO, the first randomised trial of a molecular chlamydia and gonorrhoea point-of-care assay

AU - Natoli, L

AU - Guy, R

AU - Hengel, B

AU - Causer, L

AU - Badman, S

AU - Tangey, A

AU - Tabrizi, S N

AU - Whiley, David

AU - Donovan, B

AU - Fairley, C

AU - Shephard, Mark

AU - Anderson, D

AU - Wand, H

AU - Wilson, D

AU - Regan, D

AU - Ward, J

AU - Kaldor, J M

PY - 2013/10/23

Y1 - 2013/10/23

N2 - Background: Point-of-care (POC) tests for sexually transmitted infections may increase timely diagnosis, treatment and partner notification, and thereby reduce community infection rates. With new, portable and highly accurate molecular diagnostic technology available through the GeneXpert®, we designed TTANGO (Test, Treat ANd GO), to measure the effectiveness, cost-effectiveness, cultural and operational acceptability of POC testing for chlamydia (CT) and gonorrhoea (NG) in remote Australian Aboriginal communities, where these infections occur at high levels. The trial employs a crossover, randomised controlled design at 12 health services in remote Australia. We describe the preparatory phase of the trial.

AB - Background: Point-of-care (POC) tests for sexually transmitted infections may increase timely diagnosis, treatment and partner notification, and thereby reduce community infection rates. With new, portable and highly accurate molecular diagnostic technology available through the GeneXpert®, we designed TTANGO (Test, Treat ANd GO), to measure the effectiveness, cost-effectiveness, cultural and operational acceptability of POC testing for chlamydia (CT) and gonorrhoea (NG) in remote Australian Aboriginal communities, where these infections occur at high levels. The trial employs a crossover, randomised controlled design at 12 health services in remote Australia. We describe the preparatory phase of the trial.

KW - Chlamydia

KW - Gonorrhoea

KW - Point-of-Care

M3 - Poster

SP - 251

T2 - Australasian Sexual Health Conference

Y2 - 21 October 2013 through 25 October 2013

ER -

TTANGO, the first randomised trial of a molecular chlamydia and gonorrhoea point-of-care assay

Abstract

Conference

Keywords

Access to Document

Fingerprint

Cite this